Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib

Masahiro SekimizuDepartment of PediatricsCorrespondence[email protected]

Yuka YamashitaClinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan

Hideaki UekiDepartment of Pediatrics

Nobuhiro AkitaDepartment of Pediatrics

Hiroyoshi HattoriDepartment of Pediatrics;Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan

Naoko MaedaDepartment of Pediatrics

Keizo HoribeDepartment of Pediatrics;Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan

show all

"Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib." Leukemia & Lymphoma, 55(7), pp. 1652–1653

Potential conflict of interest:

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib

Information for

Open access

Opportunities

Help and information

Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib

Potential conflict of interest:

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature